Cefdaloxime

In today's world, Cefdaloxime is a topic that has become increasingly relevant. Whether on a personal, professional or social level, Cefdaloxime has managed to spark the interest of a wide variety of individuals and organizations. Its impact has been reflected in various areas, from technology to entertainment, including health and education. In this article, we will explore Cefdaloxime in depth, analyzing its implications, challenges, and possible solutions. Additionally, we will examine how Cefdaloxime has evolved over time and the impact it has had on modern society.

Cefdaloxime
Clinical data
ATC code
  • None
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC14H15N5O6S2
Molar mass413.42 g·mol−1
3D model (JSmol)
  • O=C2N1/C(=C(\CS12NC(=O)C(=N\O)/c3nc(sc3)N)COC)C(=O)O
  • InChI=1S/C14H15N5O6S2/c1-25-2-5-3-26-12-8(11(21)19(12)9(5)13(22)23)17-10(20)7(18-24)6-4-27-14(15)16-6/h4,8,12,24H,2-3H2,1H3,(H2,15,16)(H,17,20)(H,22,23)/b18-7-/t8-,12-/m1/s1
  • Key:HOGISBSFFHDTRM-GHXIOONMSA-N
  (verify)

Cefdaloxime (INN) is a third-generation cephalosporin antibiotic.[1]

References

  1. ^ Sader HS, Runyon BA, Erwin ME, Jones RN (February 1995). "Antimicrobial activity of 11 newer and investigational drugs tested against aerobic isolates from spontaneous bacterial peritonitis". Diagnostic Microbiology and Infectious Disease. 21 (2): 105–10. doi:10.1016/0732-8893(94)00148-p. PMID 7628189.
Stub icon

This systemic antibiotic-related article is a stub. You can help Wikipedia by expanding it.